• Protocols

• UW22022

  OPEN TO ACCRUAL

  Phase II Randomized Trial of Temozolomide and Atezolizumab as Second or ThirdLine Treatment for SCLC
  
  

• UW23030

  OPEN TO ACCRUAL

  DARES
  
  

• UW23047

  OPEN TO ACCRUAL

  Ph 3 Atezolizumab-Controlled Study of HLX10 + Chemo (Carboplatin-Etoposide) in Patients with ES-SCLC